This review is part of the PlexusDx Education Hub, a resource covering GLP-1 therapies, weight-management protocols, and the genetic variables that influence how any program performs
Last reviewed: July 2, 2026 Last updated: July 2, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
using escalating dosing, as follows: 0.01 mg/kg semaglutide twice weekly for week one, 0.03 mg/kg semaglutide twice weekly for week two and 0.05 mg/kg semaglutide twice weekly for week three (as shown in Fig
An alternative method to reduce the pyloric diameter is by use of argon plasma coagulation (APC) on the anterior and apical surface of the pylorus and by using hemoclips
Semaglutide injections affect every patient differently, so the optimal amount differs for everyone
But that study stopped early because of a futility analysis